Patent Assignment
Reel/Frame 068605/0741
Assignment of Assignor's Interest
Recorded: 2024-09-17
Pages: 6
Assignor
CUREVAC SE
Executed: 2024-09-03
Assignee
GLAXOSMITHKLINE BIOLOGICALS SA
RUE DE L'INSTITUT 89, RIXENSART, B-1330, BELGIUM
Covered Property
(1)
RNA vaccine against SARS-CoV-2 variants
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 9, 2022
From: ROTH, NICOLE, DR.; MORENO, DIEGO CHAVES; GROSSE, HANS WOLFGANG, DR.; VAHRENHORST, DOMINIK
To: CUREVAC AG; GLAXOSMITHKLINE BIOLOGICALS SA
Reel/Frame 058938/0857 →
Change of Name
May 16, 2023
From: CUREVAC AG
To: CUREVAC SE
Reel/Frame 063662/0455 →
Corrective Assignment to Correct the the Recorded Assignment to Include the Authorized Signatory's Printed Name for Curevac Se. Previously Recorded on Reel 68605 Frame 741. Assignor(S) Hereby Confirms the Assignment.
Sep 27, 2024
From: CUREVAC SE
To: GLAXOSMITHKLINE BIOLOGICALS SA
Reel/Frame 069068/0321 →